Basit öğe kaydını göster

dc.contributor.authorYazici, Halil
dc.contributor.authorTurkmen, Aydin
dc.contributor.authorCarin, Mahmut Nezih
dc.contributor.authorAydin, Ali Emin
dc.contributor.authorOguz, Fatma Savran
dc.contributor.authorOnal, Ayşe Emel
dc.contributor.authorSever, Mehmet Sukru
dc.contributor.authorEldegez, Ulug
dc.contributor.authorKekik, Cigdem
dc.contributor.authorKarahan, Gonca Emel
dc.contributor.authorSeyhun, Yalcin
dc.date.accessioned2021-03-04T19:25:36Z
dc.date.available2021-03-04T19:25:36Z
dc.date.issued2009
dc.identifier.citationKarahan G. E. , Seyhun Y., Oguz F. S. , Kekik C., Onal A. E. , Yazici H., Turkmen A., Aydin A. E. , Sever M. S. , Eldegez U., et al., "Impact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease", RENAL FAILURE, cilt.31, ss.44-49, 2009
dc.identifier.issn0886-022X
dc.identifier.othervv_1032021
dc.identifier.otherav_8fb7f22f-5dea-4555-a74d-3fe694a70eac
dc.identifier.urihttp://hdl.handle.net/20.500.12627/97039
dc.identifier.urihttps://doi.org/10.1080/08860220802546297
dc.description.abstractThe number of patients with end stage renal disease (ESRD) is increasing faster than the number of renal transplantations performed per year worldwide. Of the primary diseases leading to ESRD, diabetic nephropathy is the leading cause. The purpose of the present study is to investigate the association of HLA with the primary diseases leading to ESRD in Turkish patients. A total of 3230 individuals comprising 587 ESRD patients and 2643 healthy controls were enrolled into the study. Class I HLA-A, -B typing was performed by CDC method, while class II HLA-DRB1 typing was performed by low resolution PCR-SSP. We found a significant negative association between almost all A locus antigens and primary disease groups classified as chronic glomerulonephritis and hypertensive nephrosclerosis (p 0.05). HLA-B58 and HLA-DRB1*03 significantly correlated with amyloidosis and diabetic nephropathy, respectively. Determination of HLAs as risk factors for primary diseases leading to ESRD might be beneficial in preventing progression to ESRD and recurrence of the primary disease post-transplantation.
dc.language.isoeng
dc.subjectNefroloji
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.titleImpact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease
dc.typeMakale
dc.relation.journalRENAL FAILURE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume31
dc.identifier.issue1
dc.identifier.startpage44
dc.identifier.endpage49
dc.contributor.firstauthorID30204


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster